Company news

Tilray Brands, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Tilray Medical Launches Sleep-Oriented CBN Night Oil for Medical Cannabis Patients in Canada

June 6, 2022

Tilray Launches CBD Lifestyle Brand, Pollen, on Amazon UK

May 25, 2022

Good Supply Brand Expands High-Potency Cannabis Portfolio with Launch of Liquid Wax Vapes and New Exclusive Strains

May 11, 2022

Tilray Brands Announces Definitive Agreement With Hexo Corp. Related to Hexo’s Senior Secured Convertible Note

April 11, 2022

Tilray Brands, Inc. Reports Third Quarter Fiscal Year 2022 Financial Results

April 5, 2022

Solei Brand Launches the First Cannabis Edible Available in Quebec

April 4, 2022

Tilray Brands to Announce Third Quarter Fiscal 2022 Financial Results on April 6, 2022

March 29, 2022

Tilray Medical Expands Offering in Malta and Launches First Medical Cannabis Oil Products in Market

March 16, 2022

Good Supply Brand Expands Its Award-Winning Cannabis Portfolio with Hash Bats™; A New ‘Hard-Hitting’ Infused Pre-Roll

March 7, 2022

Tilray Brands Announces Proposed Agreement for Strategic Alliance With Hexo Corp.

March 2, 2022

Tilray Launches Medical Cannabis Products in Malta

February 16, 2022

Tilray Brands Consolidates its Global Medical Offering into Tilray Medical, a Comprehensive Portfolio of Brands and Products

February 7, 2022

Tilray Expands Medical Cannabis Product Offering in Australia

January 24, 2022

Tilray, Inc. Reports Profitable Second Quarter Fiscal Year 2022 Financial Results

January 9, 2022

Tilray to Announce Second Quarter Fiscal 2022 Financial Results on January 10, 2022

December 19, 2021

Tilray Strengthens Strategic Position in the U.S. with Acquisition of Breckenridge Distillery

December 7, 2021

Tilray to Webcast Annual Meeting of Stockholders on November 22, 2021

November 15, 2021

Tilray’s Sweetwater Brand Enters Spirits Category Through New Ready-To-Drink Cocktail Now Available in the United States

November 3, 2021

Tilray Expands Medical Cannabis Footprint in Europe

October 25, 2021

Tilray Signs Distribution Agreement With Great North Distributors for Adult-Use Cannabis Sales Across Canada

October 19, 2021

Tilray Strengthens Leadership Position in Canada

October 18, 2021

Tilray, Inc. Reports First Quarter Fiscal Year 2022 Financial Results

October 6, 2021

Tilray to Announce First Quarter Fiscal 2022 Financial Results on October 7, 2021

September 22, 2021

Tilray Stockholders Approve Proposal to Increase Authorized Shares at Special Meeting

September 9, 2021

Tilray Announces Adjournment of Special Meeting of Stockholders to September 10, 2021

August 18, 2021

Tilray Acquires Majority Position in Amended MedMen Convertible Notes

August 16, 2021

Tilray Launches New Medical Cannabis Edibles in Canada

August 4, 2021

Tilray Announces Adjournment of Special Meeting of Stockholders to August 19, 2021

July 28, 2021

Tilray, Inc. Reports 2021 Fiscal Year and Fourth Quarter Results

July 27, 2021

Tilray to Announce Fourth Quarter and Fiscal 2021 Financial Results on July 28, 2021

July 14, 2021

Tilray’s Aphria RX GmbH Subsidiary Completes First Successful Harvest and Delivery of Medical Cannabis Grown in Germany

July 6, 2021

Tilray Introduces Its First Cross-brand Product Collaboration and Launches Canadian Craft Cannabis Brand, Broken Coast, in the U.S.

June 29, 2021

Tilray Asks Stockholders to Support Key Initiatives to Drive Strategic Growth and Strengthen Stockholder Rights

June 28, 2021

Tilray Announces Launch of New Medical Cannabis Brand, Symbios

June 7, 2021

Tilray Commences Trading on the Toronto Stock Exchange Under Symbol “TLRY”

May 4, 2021

Tilray & Aphria Announce Closing of Transaction That Creates the “New” Tilray – a Global Cannabis Leader

May 2, 2021

Tilray Board of Directors Announces Approval of Amendment to Company’s Bylaws; Aphria and Tilray Announce Waiver of Charter Amendment Proposal Requirement

April 15, 2021

Special Meeting of Tilray, Inc. Stockholders Adjourned to April 30, 2021 at 11: 00 a.m. Eastern Time

April 14, 2021

MAKE YOUR VOTE COUNT!: Tilray Reminds Shareholders to Vote FOR the Proposed Business Combination With Aphria Inc.

April 11, 2021

Tilray® Receives Approvals to Expand and Commercialize Medical Cannabis Products in New Zealand

March 9, 2021

Aphria and Tilray Announce Launch of www.aphriatilraytogether.com

February 22, 2021

Tilray, Inc. Reports 2020 Full Fiscal Year and Fourth Quarter Results

February 16, 2021

Tilray to Report 2020 Full Fiscal Year and Fourth Quarter Financial Results on February 17, 2021

February 11, 2021

Tilray® Announces Agreement with Grow Pharma to Import and Distribute Medical Cannabis Products in the United Kingdom

February 8, 2021

Tilray® Exports First Shipment of Medical Cannabis to Spain

February 3, 2021

Tilray® Receives the First and Only Market Authorization to Offer Medical Cannabis Products in Portugal

January 31, 2021

Tilray® Selected by French National Agency to Supply GMP-Certified Medical Cannabis Products in France

January 25, 2021

Tilray, Inc. and Hormosan Sign a Cooperation Agreement for the Promotion of Medical Cannabis Extracts in Germany

December 1, 2020

Tilray, Inc. Announces Agreement to Exchange an Additional $72.9 Million in Principal Amount of Its 5.00% Convertible Senior Notes Due 2023 for Common Stock

November 23, 2020

Tilray, Inc. Announces Agreement to Exchange Approximately $124.3 Million in Principal Amount of Its 5.00% Convertible Senior Notes Due 2023 for Common Stock

November 22, 2020

← Newer news releases · Older news releases →

Calls

The 5 newest of 24 calls. Every call is listed under its year.

Decks